SeaCrest Wealth Management’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

SeaCrest Wealth Management’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$3K	–	2360
2018 Q3	$3K	Hold	100	–	–	﹤0.01%	2018
2018 Q2	$3K	Hold	100	–	–	﹤0.01%	1961
2018 Q1	$2K	Buy	+100	New	+$2.57K	﹤0.01%	2032

Other funds holding LDRS

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

SeaCrest Wealth Management's LDRS Position: Q4 2018 in Review

SeaCrest Wealth Management sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q4 2018, closing a stake of 100 shares — an estimated $3K sold.

SeaCrest Wealth Management first reported a position in LDRS in Q1 2018 and held it in 3 quarters. The position peaked at $3K in Q3 2018. 13 funds tracked by Wall St. Rank hold LDRS as of Q4 2018.

SeaCrest Wealth Management reported no remaining Innovator IBD ETF Leaders ETF position as of Q4 2018 after selling out during the quarter.
SeaCrest Wealth Management sold 100 Innovator IBD ETF Leaders ETF shares in Q4 2018, an estimated $3K.
SeaCrest Wealth Management first reported a position in Innovator IBD ETF Leaders ETF in Q1 2018 and held it in 3 quarters.
SeaCrest Wealth Management's Innovator IBD ETF Leaders ETF position peaked at $3K in Q3 2018.
13 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q4 2018.

Based on SeaCrest Wealth Management's 13F filing for Q4 2018, filed 13 Feb 2019.